Search Results
Imugene's Leslie Chong outlines key strategic partnership with Celularity
Imugene's Leslie Chong welcomes IND approval for CHECKvacc trial
Imugene + Celularity Announce an Exclusive Strategic Partnership to Develop a Novel Oncolytic Virus.
Imugene's Leslie Chong thrilled with two significant FDA IND approvals
Imugene's Leslie Chong welcomes strong support for its $90 million placement
Imugene (ASX: IMU) – New Global Partnership Announced For This Leading ASX Biotech
Imugene (ASX: IMU) – The ‘Holy Grail’ Of Cancer Treatment…?! | ASX CEO Interview 🚀📈
Imugene Presentation – NWR Virtual Investor Conference (Series 8)
Imugene CEO hails clinical milestone for HER-Vaxx cancer immunotherapy
A clinical stage immuno-oncology company.
Imugene's new cancer therapy CD19 (OnCARlytics) considered the 'Holy Grail'
Imugene (ASX: IMU) - Discussing IMU's 2022 Biotech Opportunity
